J. Kopp

发表

Influence of CD80, Interleukin-2, and Interleukin-7 Expression in Human Renal Cell Carcinoma on the Expansion, Function, and Survival of Tumor-Specific CTLs

G. Willimsky, T. Blankenstein, E. Noessner, 2005, Clinical Cancer Research.

Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study

B. Dörken, G. Willimsky, T. Blankenstein, 2011, Gene Therapy.

Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma.

C. Stief, A. Baur-Melnyk, G. Willimsky, 2010, Human gene therapy.

DC generation from peripheral blood mononuclear cells in patients with chronic myeloid leukemia: Influence of interferons on DC yield and functional properties

B. Dörken, U. Kölsch, C. Meisel, 2016, Human vaccines & immunotherapeutics.

Vaccination with autologous non‐irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia

B. Dörken, K. Döhner, H. Döhner, 2007, British journal of haematology.

Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia

B. Dörken, T. Blankenstein, Z. Qin, 2000, Bone Marrow Transplantation.

Immunotherapy of B-cell lymphoma with CD3x19 bispecific antibodies: costimulation via CD28 prevents "veto" apoptosis of antibody-targeted cytotoxic T cells.

B. Dörken, I. Sturm, P. Daniel, 1998, Blood.

Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties

B. Dörken, M. Zenke, I. Körner, 2003, Cancer Immunology, Immunotherapy.

The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.

S. Lolekha, M. Lopata, S. Gotoff, 1973, The Journal of laboratory and clinical medicine.

Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer

B. Dörken, K. Egerer, B. Sawitzki, 2013, Human vaccines & immunotherapeutics.

High Immune Response Rates and Decreased Frequencies of Regulatory T Cells in Metastatic Renal Cell Carcinoma Patients after Tumor Cell Vaccination

S. Stevanović, C. Stief, G. Willimsky, 2012, Molecular medicine.

Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26 / CD 80 / IL-2 in Patients with Metastatic Renal Cell Carcinoma

C. Stief, G. Willimsky, T. Blankenstein, 2010 .

Granulocyte/macrophage-colony-stimulating-factor plus interleukin-2 plus interferon α in the treatment of metastatic renal cell carcinoma: a pilot study

B. Dörken, U. Haus, J. Westermann, 2001, Cancer Immunology, Immunotherapy.

Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene‐modified allogeneic tumor cell vaccine in advanced renal cell cancer: Tumor‐induced immunosuppression and a possible role for NF‐κB

Peter Lenz, Annette Wolf, Michael Grau, 2015, International journal of cancer.

Dendritic Cells Vaccination in BCR/ABL-Positive Chronic Myeloid Leukemia - Final Results of a Phase I/II Study.

B. Dörken, H. Döhner, P. Coutre, 2004 .

Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma

C. Stief, G. Willimsky, T. Blankenstein, 2010 .

The HIV‐1 Surface Protein gp120 Has No Effect on Transmembrane Signal Transduction in T Cells

F. Hucho, C. Rudd, K. Buchner, 1992, Journal of acquired immune deficiency syndromes.